AMERICAN HEALTHCARE REIT INC (AHR) Stock Fundamental Analysis
NYSE:AHR - New York Stock Exchange, Inc. - US3981823038 - REIT - Currency: USD
AHR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 130 industry peers in the Diversified REITs industry. AHR may be in some trouble as it scores bad on both profitability and health. AHR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
AHR had negative earnings in the past year.
AHR had a positive operating cash flow in the past year.
1.2 Ratios
AHR has a Return On Assets of -0.91%. This is in the lower half of the industry: AHR underperforms 66.15% of its industry peers.
AHR's Return On Equity of -1.80% is on the low side compared to the rest of the industry. AHR is outperformed by 62.31% of its industry peers.
AHR has a Return On Invested Capital of 2.92%. This is comparable to the rest of the industry: AHR outperforms 58.46% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AHR is in line with the industry average of 3.15%.
The 3 year average ROIC (1.94%) for AHR is below the current ROIC(2.92%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.91% | ||
| ROE | -1.8% | ||
| ROIC | 2.92% |
ROA(3y)-1.37%
ROA(5y)N/A
ROE(3y)-4.37%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
1.3 Margins
With a Operating Margin value of 7.08%, AHR is not doing good in the industry: 83.08% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of AHR has grown nicely.
With a Gross Margin value of 20.32%, AHR is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
AHR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.08% | ||
| PM (TTM) | N/A | ||
| GM | 20.32% |
OM growth 3Y31.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AHR is destroying value.
The number of shares outstanding for AHR has been increased compared to 1 year ago.
AHR has a better debt/assets ratio than last year.
2.2 Solvency
AHR has an Altman-Z score of 1.80. This is a bad value and indicates that AHR is not financially healthy and even has some risk of bankruptcy.
AHR has a Altman-Z score of 1.80. This is amongst the best in the industry. AHR outperforms 95.38% of its industry peers.
AHR has a debt to FCF ratio of 22.99. This is a negative value and a sign of low solvency as AHR would need 22.99 years to pay back of all of its debts.
The Debt to FCF ratio of AHR (22.99) is better than 76.92% of its industry peers.
AHR has a Debt/Equity ratio of 0.74. This is a neutral value indicating AHR is somewhat dependend on debt financing.
AHR has a Debt to Equity ratio of 0.74. This is in the better half of the industry: AHR outperforms 75.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 22.99 | ||
| Altman-Z | 1.8 |
ROIC/WACC0.38
WACC7.71%
2.3 Liquidity
A Current Ratio of 0.72 indicates that AHR may have some problems paying its short term obligations.
AHR has a Current ratio of 0.72. This is in the lower half of the industry: AHR underperforms 63.85% of its industry peers.
A Quick Ratio of 0.72 indicates that AHR may have some problems paying its short term obligations.
With a Quick ratio value of 0.72, AHR is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 63.48% over the past year.
AHR shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.34%.
Measured over the past years, AHR shows a quite strong growth in Revenue. The Revenue has been growing by 17.32% on average per year.
EPS 1Y (TTM)63.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%325%
Revenue 1Y (TTM)10.34%
Revenue growth 3Y17.32%
Revenue growth 5YN/A
Sales Q2Q%8.22%
3.2 Future
AHR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 76.69% yearly.
The Revenue is expected to grow by 8.05% on average over the next years. This is quite good.
EPS Next Y234.67%
EPS Next 2Y111.4%
EPS Next 3Y76.69%
EPS Next 5YN/A
Revenue Next Year8.81%
Revenue Next 2Y7.76%
Revenue Next 3Y8.05%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AHR. In the last year negative earnings were reported.
AHR is valuated quite expensively with a Price/Forward Earnings ratio of 59.48.
AHR's Price/Forward Earnings is on the same level as the industry average.
AHR is valuated expensively when we compare the Price/Forward Earnings ratio to 36.36, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 59.48 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AHR is valued more expensive than 90.77% of the companies in the same industry.
AHR's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 86.66 | ||
| EV/EBITDA | 24.21 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AHR's earnings are expected to grow with 76.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y111.4%
EPS Next 3Y76.69%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.59%, AHR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 6.85, AHR's dividend is way lower than its industry peers. On top of this 82.31% of the companies listed in the same industry pay a better dividend than AHR!
Compared to an average S&P500 Dividend Yield of 2.40, AHR has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.59% |
5.2 History
AHR is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of AHR are negative and hence is the payout ratio. AHR will probably not be able to sustain this dividend level.
DP-353.22%
EPS Next 2Y111.4%
EPS Next 3Y76.69%
39.65
-0.41 (-1.02%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners97.91%
Inst Owner Change0.39%
Ins Owners0.85%
Ins Owner Change8.04%
Market Cap6.32B
Analysts82.86
Price Target41.31 (4.19%)
Short Float %3.4%
Short Ratio3.35
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.59% |
Yearly Dividend1.08
Dividend Growth(5Y)N/A
DP-353.22%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-144.27%
Min EPS beat(2)-359.9%
Max EPS beat(2)71.36%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.21%
Min Revenue beat(2)-0.4%
Max Revenue beat(2)-0.01%
Revenue beat(4)1
Avg Revenue beat(4)1.21%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)6.85%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.25%
PT rev (3m)19.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)15.56%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.37%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)0.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 59.48 | ||
| P/S | 2.99 | ||
| P/FCF | 86.66 | ||
| P/OCF | 26.06 | ||
| P/B | 2.8 | ||
| P/tB | 3.38 | ||
| EV/EBITDA | 24.21 |
EPS(TTM)-0.14
EYN/A
EPS(NY)0.67
Fwd EY1.68%
FCF(TTM)0.46
FCFY1.15%
OCF(TTM)1.52
OCFY3.84%
SpS13.24
BVpS14.18
TBVpS11.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.91% | ||
| ROE | -1.8% | ||
| ROCE | 3.7% | ||
| ROIC | 2.92% | ||
| ROICexc | 2.99% | ||
| ROICexgc | 3.35% | ||
| OM | 7.08% | ||
| PM (TTM) | N/A | ||
| GM | 20.32% | ||
| FCFM | 3.46% |
ROA(3y)-1.37%
ROA(5y)N/A
ROE(3y)-4.37%
ROE(5y)N/A
ROIC(3y)1.94%
ROIC(5y)N/A
ROICexc(3y)1.97%
ROICexc(5y)N/A
ROICexgc(3y)2.22%
ROICexgc(5y)N/A
ROCE(3y)2.45%
ROCE(5y)N/A
ROICexcg growth 3Y56.38%
ROICexcg growth 5YN/A
ROICexc growth 3Y56.96%
ROICexc growth 5YN/A
OM growth 3Y31.86%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5YN/A
F-Score7
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 22.99 | ||
| Debt/EBITDA | 5.13 | ||
| Cap/Depr | 95.57% | ||
| Cap/Sales | 8.03% | ||
| Interest Coverage | 1.47 | ||
| Cash Conversion | 74.2% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 1.8 |
F-Score7
WACC7.71%
ROIC/WACC0.38
Cap/Depr(3y)83.56%
Cap/Depr(5y)N/A
Cap/Sales(3y)7.98%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%325%
EPS Next Y234.67%
EPS Next 2Y111.4%
EPS Next 3Y76.69%
EPS Next 5YN/A
Revenue 1Y (TTM)10.34%
Revenue growth 3Y17.32%
Revenue growth 5YN/A
Sales Q2Q%8.22%
Revenue Next Year8.81%
Revenue Next 2Y7.76%
Revenue Next 3Y8.05%
Revenue Next 5YN/A
EBIT growth 1Y57.11%
EBIT growth 3Y54.7%
EBIT growth 5YN/A
EBIT Next Year163.11%
EBIT Next 3Y45.97%
EBIT Next 5YN/A
FCF growth 1Y151.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y78.71%
OCF growth 3Y114.22%
OCF growth 5YN/A